March 20, 2012
/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at ZELTIQ Aesthetics, Inc. ("ZELTIQ" or the "Company") (NASDAQ: ZLTQ).
Faruqi & Faruqi is investigating allegations that ZELTIQ executives misled investors by failing to disclose material information about the delayed sale of Company products and increased competition from a competitor's Liposonix business.
March 6, 2012
, shares of ZELTIQ plummeted after the Company announced fourth quarter 2011 sales and profits that fell well below analyst estimates. ZELTIQ reported a loss per share of
, while analysts had been expecting a per share loss of only
. In addition, ZELTIQ predicted 2012 sales in the range of
$90 million to $94 million
, well below analyst expectations of
In the days following this extremely disappointing news, ZELTIQ's stock price lost nearly 47% of its value – falling from
per share on
March 5, 2012
, to only
per share on
March 8, 2012
Request more information now by clicking here:
If you purchased ZELTIQ securities and would like to discuss your legal rights, visit
. You can also contact us by calling
toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to
. Faruqi & Faruqi, LLP also encourages anyone with information regarding ZELTIQ's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (
). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential matter.
FARUQI & FARUQI, LLP369 Lexington Avenue, 10th Floor
New York, NY
Richard Gonnello, Esq.
Francis McConville, Esq.
Telephone: (877) 247-4292 or (212) 983-9330
SOURCE Faruqi & Faruqi, LLP